| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = -$272,522 ) |
| | 2027 | 2026 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | T42OH010278 | OCCUPATIONAL SAFETY AND HEALTH EDUCATION AND RESEARCH CENTERS (T42) | 01 | 13 | CDC | 10/26/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA064647 | Systematic Assessment of Cannabinoid Interactions: Impairment, Abuse Potential and Pharmacokinetic Effects | 000 | 1 | NIH | 10/21/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R00AR081367 | Contribution of ribosome specialization to the pathophysiology of muscular dystrophy | 000 | 5 | NIH | 10/21/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U7A50519 | State Maternal Health Innovation Program | 01 | 4 | HRSA | 10/2/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU87DP000047 | Adolescent Health and Schools ProgramsAssistance Listing Number 93.07 | 02 | 3 | CDC | 10/2/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU87DP000047 | Adolescent Health and Schools ProgramsAssistance Listing Number 93.07 | 02 | 3 | CDC | 10/2/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU87DP000047 | Adolescent Health and Schools ProgramsAssistance Listing Number 93.07 | 02 | 3 | CDC | 10/2/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | UM1TR006383 | Kentucky Center for Clinical and Translational Science | 000 | 1 | NIH | 10/22/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | G08LM014412 | DASH-ing to Heart Health: Supporting Low-Income African American Women with an Interactive "Meals that Heal" Resource Book | 000 | 3 | NIH | 10/26/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES033767 | Phthalate-Induced Dysregulation of Prostaglandin and Angiogenic Function During Ovulation in Women | 000 | 5 | NIH | 10/8/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P50MD019476 | UK ASCEND (Achieving Success in Community-Engaged research to elimiNate Disparities) | 000 | 3 | NIH | 10/29/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | T9952106 | Value-Based Medical Student Education Training Program | 01 | 4 | HRSA | 10/21/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA065557 | Effects of the Orexin Dual Receptor Antagonist Suvorexant on Cannabis Withdrawal and Self-Administration: a Controlled Inpatient Human Laboratory Study in People with Cannabis Use Disorder | 000 | 1 | NIH | 10/14/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31AA031600 | Uncovering the functional and mechanistic dysregulation of monocytes after abstinence and post-abstinence drinking | 000 | 2 | NIH | 10/15/2026 | -$3,239 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | S15OD039798 | Modernization of Sterilization Equipment in the UK Todd Vivarium | 000 | 1 | NIH | 10/21/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA196634 | Improving chemotherapy of castration-resistant prostate cancer. | 000 | 11 | NIH | 10/14/2026 | -$646 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU87DP000047 | Adolescent Health and Schools ProgramsAssistance Listing Number 93.07 | 02 | 3 | CDC | 10/2/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU87DP000047 | Adolescent Health and Schools ProgramsAssistance Listing Number 93.07 | 02 | 3 | CDC | 10/2/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU87DP000047 | Adolescent Health and Schools ProgramsAssistance Listing Number 93.07 | 02 | 3 | CDC | 10/2/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU87DP000047 | Adolescent Health and Schools ProgramsAssistance Listing Number 93.07 | 02 | 3 | CDC | 10/2/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU17CE010186 | CDC-RFA-CE-23-0002 Overdose Data to Action | 03 | 3 | CDC | 10/1/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K08DK124566 | Muscle bone interaction and its role in diabetic bone disease of Type I diabetes | 000 | 5 | NIH | 10/22/2026 | -$1,852 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31HL170558 | The myosin super-relaxed state and human dilated cardiomyopathy | 000 | 2 | NIH | 10/27/2026 | -$3,794 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG037868 | Chronic Stress, Glucocorticoids, and Progesterone in Brain Aging | 000 | 10 | NIH | 10/13/2026 | -$13,093 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AA030487 | Evaluation of a Combined Motivational Interviewing and Ecological Momentary Intervention to Reduce Risky Alcohol Use among Individuals Vulnerable to HIV/AIDS | 000 | 4 | NIH | 10/9/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AI184710 | Interactions between drug combinations and resistance acquisition risk for antimalarial ATP4 inhibitors | 000 | 2 | NIH | 10/15/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31DA057812 | Role of Dynamic Signaling of NRG3-ErbB4 in the Prefrontal Cortex in Mediating Nicotine Withdrawal Phenotypes | 000 | 2 | NIH | 10/27/2026 | -$30,903 |
| | 2027 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F30AG079506 | Investigating Enlarged Perivascular Spaces as a Neuroimaging Biomarker of Cerebral Small Vessel Disease | 000 | 3 | NIH | 10/27/2026 | -$10,460 |
| | 2027 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU17CE010186 | CDC-RFA-CE-23-0002 Overdose Data to Action | 03 | 3 | CDC | 10/1/2026 | $0 |
| | 2027 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA049333 | Research Examining Factors Associated with the Opioid Crisis among Underserved African Americans (REFOCUS) | 000 | 5 | NIH | 10/26/2026 | -$5,216 |
| | 2027 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01MD015304 | Geographic and Racial Disparities in Mammography Screening and Barriers to Receiving Care | 000 | 5 | NIH | 10/23/2026 | -$14,974 |
| | 2027 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | H79SM082826 | Secondary Traumatic Stress Innovation and Solution Center (STS-ISC) | 000 | 5 | SAMHSA | 10/19/2026 | -$1,475 |
| | 2027 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AA028447 | Impaired Risk Awareness during Intoxication in Recidivist DUI Offenders | 000 | 4 | NIH | 10/9/2026 | -$29,468 |
| | 2027 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK135267 | Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance | 000 | 2 | NIH | 10/12/2026 | $0 |
| | 2027 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK125801 | Enhancing the Diabetes Prevention Program to promote weight loss among non-responders in a community based lifestyle intervention | 000 | 5 | NIH | 10/26/2026 | -$18,710 |
| | 2027 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AG081761 | A Refined Murine Model of Post-sepsis Cognitive Impairment for Investigating Mitochondrial Abnormalities and Human ApoE4 Gene Polymorphisms | 000 | 2 | NIH | 10/26/2026 | -$482 |
| | 2027 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU17CE010186 | CDC-RFA-CE-23-0002 Overdose Data to Action | 03 | 3 | CDC | 10/1/2026 | $0 |
| | 2027 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA047952 | Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: the Kentucky Viral Hepatitis Treatment (KeY Treat) Study | 000 | 5 | NIH | 10/28/2026 | $0 |
| | 2027 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA047952 | Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: the Kentucky Viral Hepatitis Treatment (KeY Treat) Study | 000 | 5 | NIH | 10/28/2026 | -$138,207 |
|
| Issue Date FY: 2026 ( Subtotal = $183,877,140 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R61DA064790 | Support Towards Addiction Recovery for Individuals with Criminal Legal System Involvement: The STAR Project | 000 | 1 | NIH | 2/24/2026 | $422,921 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HL185125 | The role of Asprosin-Ptprd signaling in the neural control of blood pressure | 000 | 1 | NIH | 7/8/2026 | $724,259 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01MH143819 | ADHD and its Cognition and Affective Mechanisms During Adolescence | 000 | 1 | NIH | 8/26/2026 | $2,695,895 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U2FFD008699 | University of Kentucky Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives | 003 | 2 | FDA | 9/14/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U2FFD008699 | University of Kentucky Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives | 002 | 2 | FDA | 7/27/2026 | $224,999 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13DC024048 | Midwest Auditory Research Conference | 000 | 1 | NIH | 8/25/2026 | $58,000 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AG095587 | Multiscale Microgels Delivering GDNF and Agrin with Resistance Training to Enhance Outcomes in Sarcopenia | 000 | 1 | NIH | 8/26/2026 | $590,826 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | OT2ES038696 | The East Palestine Train Derailment Health Research Program | 003 | 1 | NIH | 9/1/2026 | $988,735 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R00HD108801 | Sex and physiological State dependent molecular characterization of circuits governing parental behavior | 001 | 4 | NIH | 8/14/2026 | $224,100 |
|
